The present invention is related to the use of Cladribine for the preparation of a pharmaceutical formulation for the treatment of multiple sclerosis, especially relapsing-remitting multiple sclerosis or early secondary progressive multiple sclerosis, wherein the preparation is to be orally administered and wherein re-treatments are possible.

 
Web www.patentalert.com

< Abuse-resistant amphetamine prodrugs

< Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides

> Compositions of an anticonvulsant and mirtazapine to prevent weight gain

> Imidazo[2,1-b ]-1,3,4-thiadiazole sulfonamides
~ 00605